These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 2446483
1. [Hormonal environment following treatment with a small dose of estrogen--small dose of estrogen alone and in combination with an anti-androgen]. Hayashi T, Taki Y, Ikai K, Hiura M, Kiriyama T. Hinyokika Kiyo; 1987 Jul; 33(7):1035-42. PubMed ID: 2446483 [Abstract] [Full Text] [Related]
2. Inhibition of disease flare with diethylstilbestrol diphosphate and chlormadinone acetate administration for two weeks prior to slow-releasing leuprolide acetate in prostatic cancer patients. Ohuchi H, Noguchi K, Kinoshita Y, Hosaka M, Kawasaki C, Miura T, Kondo I, Harada M. Hinyokika Kiyo; 2000 Aug; 46(8):531-6. PubMed ID: 11019371 [Abstract] [Full Text] [Related]
3. [Testosterone, FSH and LH level in the serum of patients with prostatic neoplasms, treated with female hormones]. Weidner W, Krause W, Pust R, Engstfeld J, Rothauge CF. Helv Chir Acta; 1978 Jul; 45(3):287-90. PubMed ID: 701064 [Abstract] [Full Text] [Related]
4. Effects of combination therapy with a luteinizing hormone-releasing hormone agonist and chlormadinone acetate on rat prostate weight and plasma testosterone levels. Gotanda K, Shinbo A, Okada M, Nakano Y, Kobayashi H, Sasaki T, Hagiwara M, Akaza H. Prostate Cancer Prostatic Dis; 2003 Jul; 6(1):66-72. PubMed ID: 12664069 [Abstract] [Full Text] [Related]
5. A randomized phase II trial of flutamide vs chlormadinone acetate in previously untreated advanced prostatic cancer. The Japan Flutamide Study Group. Akaza H, Usami M, Kotake T, Koiso K, Aso Y. Jpn J Clin Oncol; 1993 Jun; 23(3):178-85. PubMed ID: 7688829 [Abstract] [Full Text] [Related]
6. [Clinical evaluation of CMA in the treatment of prostatic cancer]. Fukuoka H, Goto A, Murai T, Satomi Y, Moriyama M, Senga Y, Shirai K, Nakao H. Hinyokika Kiyo; 1986 Dec; 32(12):1821-30. PubMed ID: 2435131 [Abstract] [Full Text] [Related]
7. [Clinical evaluation of flutamide, a pure antiandrogen, in prostatic cancer phase II dose-finding study]. Aso Y, Akaza H, Koiso K, Kameyama S, Koyanagi T, Kawai T, Kumamoto Y, Tazaki H, Funyu T, Oshima H. Hinyokika Kiyo; 1993 Apr; 39(4):391-403. PubMed ID: 8503339 [Abstract] [Full Text] [Related]
8. [Pretreatment with chlormadinone acetate in prostate cancer patients treated with a luteinizing hormone-releasing hormone analogue]. Yamamoto A, Sumiyoshi Y, Miyake N, Yokozeki H, Kanayama H, Kagawa S. Hinyokika Kiyo; 1998 Aug; 44(8):557-63. PubMed ID: 9783191 [Abstract] [Full Text] [Related]
9. [Clinical study on chlormadinone acetate alone followed by combination with LH-RH analogue for prostatic cancer: effects on lipid metabolism]. Shimada M, Uchida H, Kasahara T, Fuji K, Ogawa Y, Yoshida H, Hamajima T, Matsuda N, Ikeuchi T, Kai Y, Hiramori M, Hoshino M, Inoue K, Higaki Y. Hinyokika Kiyo; 1998 Jul; 44(7):525-32. PubMed ID: 9752613 [Abstract] [Full Text] [Related]
17. [H2 histamine antagonists and the hypothalamo-hypophyseal-gonadal axis: effect of short-term treatment on serum levels of prolactin, FSH, LH and testosterone in male ulcer patients]. Biagi P, Galli M, Brettoni A, Rizzo AA, Massafra C. Quad Sclavo Diagn; 1983 Sep; 19(3):313-21. PubMed ID: 6146158 [Abstract] [Full Text] [Related]
19. [Inhibition of the free, biologically active testosterone level by Turisteron in patients with prostate cancer]. Stahl F, Schnorr D, Rohde W, Dörner G. Z Urol Nephrol; 1987 Mar; 80(3):135-8. PubMed ID: 3604472 [Abstract] [Full Text] [Related]
20. The effects of orchidectomy, estrogens, and cyproterone acetate on plasma testosterone, LH, and FSH concentrations in patients with carcinoma of the prostate. Varenhorst E, Wallentin L, Carlström K. Scand J Urol Nephrol; 1982 Mar; 16(1):31-6. PubMed ID: 6211762 [Abstract] [Full Text] [Related] Page: [Next] [New Search]